AKNILOX gel 4 % tb 30 g

7680513030409 CH-51303 D10AF02 10.02.0.
AKNILOX gel 4 % tb 30 g
AKNILOX gel 4 % tb 30 g
AKNILOX gel 4 % tb 30 g
1 / 3
google

Details

Product number
5130304
CPT
-
Packaging group
30
Unit
g
Composition
erythromycinum 40.0 mg, hydroxypropylcellulosum, ethanolum anhydricum 950.0 mg, ad gelatum pro 1 g.

Articles (1)

Aknilox 4%, Gel
Gel
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
06/07/2023
Patient information leaflet
Français
06/07/2023
Patient information leaflet
Italien
06/07/2023
Professional SmPC
Allemand
06/07/2023
Professional SmPC
Français
06/07/2023
Professional SmPC
Italien
06/07/2023

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
950.0 MG Substance HNIDK

Authorization holder

Drossapharm AG

4051 Basel

Authorization information

Swissmedic authorization number
51303
Drug name
Aknilox, Gel
Galenic form
GELK
ATC Code
D10AF02
Authorization status
Z
Dispensation category
B
First authorization
11/01/1993
Authorization expiration date
31/12/9999
IT number
10.02.0.
Domain
Human medicine
Field of application
Akne vulgaris

Packaging details

Description (FR)
AKNILOX gel 4 % tb 30 g
Description (DE)
AKNILOX Gel 4 % Tb 30 g
Market launch
03/09/2008
Narcotic (BTM)
No

Other packaging sizes

AKNILOX gel 2 % tb 30 g
30 G
View